Bradley P. Knight MD, FACC, FHRS

Letter from the Editor

Are Disease-Modifying Treatments on the Horizon for Patients With Arrhythmogenic Right Ventricular Cardiomyopathy?

06/26/2024

Gene therapy targeting the underlying desmosomal mutation and approaches to prevent myocardial fibrosis independent of the specific genetic defect by increasing cardiac levels of FGF21 may be on the horizon for patients with ARVC.

Gene therapy targeting the...

06/26/2024

EP Lab Digest

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

July 18 ⁠–⁠ July 19

July 19 ⁠–⁠ July 20

July 24 ⁠–⁠ July 26

July 26 ⁠–⁠ July 27

July 27 ⁠–⁠ July 28

August 8 ⁠–⁠ August 9

August 14 ⁠–⁠ August 17

August 16 ⁠–⁠ August 17

August 16 ⁠–⁠ August 18

See Full Calendar

Bradley P. Knight MD, FACC, FHRS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products